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YopH is a protein tyrosine phosphatase and an essen-





 delivers YopH into infected
host cells using a type III secretion mechanism. YopH
dephosphorylates several focal adhesion proteins
including p130Cas in human epithelial cells, resulting
in disruption of focal adhesions and cell detachment
from the extracellular matrix. How the C-terminal pro-
tein tyrosine phosphatase domain of YopH targets
specific substrates such as p130Cas in the complex
milieu of the host cell has not been fully elucidated.
An N-terminal non-catalytic domain of YopH binds
p130Cas in a phosphotyrosine-dependent manner
and functions as a novel substrate-targeting site. The
structure of the YopH protein tyrosine phosphatase
domain bound to a model phosphopeptide substrate
was solved and the resulting structure revealed a
second substrate-targeting site (‘site 2’) within the
catalytic domain. Site 2 binds to p130Cas in a phos-
photyrosine-dependent manner, and co-operates with
the N-terminal domain (‘site 1’) to promote efficient
recognition of p130Cas by YopH in epithelial cells. The
identification of two substrate-targeting sites in YopH
that co-operate to promote epithelial cell detachment
and bacterial virulence reinforces the importance of
protein–protein interactions for determining protein




















 are Gram-negative bacterial pathogens of














 cause enteritis and









 species share a number of
common virulence factors (Revell and Miller, 2001; Carn-
iel, 2002). One such virulence determinant is a type III
secretion system (TTSS) encoded on a 70 kb plasmid





 TTSS is homologous to TTSSs found in a




 TTSS exports a set of proteins (Yops and LcrV)
upon contact with host cells (Cornelis, 2002; Ramamurthi
and Schneewind, 2002). These proteins are released into
extracellular milieu, inserted into the host cell membrane
or delivered into the cytoplasm of the host cell (Cornelis,
2002; Ramamurthi and Schneewind, 2002). The Yops and





 (Cornelis, 2002; Ramamurthi and
Schneewind, 2002).
YopH is a protein tyrosine phosphatase (PTP) that is









., 1991). YopH has
been shown to uncouple multiple signal transduction path-




., 1997; Bliska, 2000). In
human epithelial cells YopH dephosphorylates several
focal adhesion proteins, including p130Cas (Cas) (Black





tion of Cas and other focal adhesion proteins by YopH
results in cellular retraction from the extracellular matrix
and inhibition of integrin-mediated bacterial invasion





The 468-amino-acid YopH protein is composed of two
modular domains linked by a proline-rich sequence. The








., 1992). The three-dimensional structure of the PTP
 























idues 403–410 form a phosphate-binding loop (P-loop)
within the active site. Substitution of the essential catalytic
Cys residue at position 403 to Ser results in a catalytically
inactive enzyme that retains the ability to bind substrates










tution of the essential catalytic Arg residue at position 409
with Ala ablates substrate binding and catalysis by YopH








., 2001). Residues 1–129 of YopH comprise an N-
terminal domain, which contains signals required for
TTSS-mediated delivery of YopH into host cells (Cornelis,
2002). The N-terminal region also binds to tyrosine-
phosphorylated proteins and functions within the host cell









., 2003). Several residues within the N-
terminal domain that are required for substrate targeting





., 2001). Three-dimensional structures
have been determined for the N-terminal domain using









., 2002). The fold of the N-terminal
domain is unlike that of SH2 or PTB domains. This region
of YopH appears to represent a novel type of phosphoty-





Previous studies revealed that YopH binds to the proto-




 via either the N-terminal
domain (hereafter referred to as ‘site 1’) or the active site
(hereafter referred to as ‘A site’) containing the substrate-








., 2001). However, inactivation of substrate-binding
activity in site 1 using the V31G mutation and in the A site
using the R409A mutation did not eliminate interaction




., 2001) (see Fig. 3), suggesting
that another substrate binding site may be present in








. (1999) have implicated an exposed loop in
the catalytic domain of YopH (residues 223–226) as being
important for efficient focal contact targeting. To determine
whether residues 223–226 of YopH could be important for


























, and immunofluorescence microscopy was used
to detect localization of YopH to focal adhesions. As











focal adhesion localization activity (compare Fig. 1B and
D). To confirm these results, the infected cells were lysed
and an interaction of Cas with YopH was assayed by
immunoprecipitation and anti-pTyr immunoblotting. A sim-
ilar amount of pTyr-containing protein p130 (correspond-











 (Fig. 1E and F, lanes 3 and 5), indicating that
residues 223–226 of YopH are dispensable for interaction
with Cas.
We have determined the crystal structure, refined to
3.0 Å resolution, of an inactive YopH catalytic domain (res-





) bound to the phosphopeptide sub-
strate DADEpYL, which is based on an autophosphoryla-




., 1994b). We have also
determined the 2.5 Å resolution structure of the wild-type
YopH complexed with the same peptide but containing
difluorophosphonomethyl-phenylalanine, a non-hydrolys-
able analogue of phosphotyrosine (DADEdfpYL). The two
crystals are isomorphous and each contains two enzyme




1 unit cell. Details of the crystals and
structure solution are shown in Table 1. While this manu-




. (2003) reported the
structure of the catalytic domain of YopH in complex with
a non-hydrolysable hexapeptide substrate.
Both crystal structures reported here show well-ordered
electron density consistent with a bound peptide at a
second substrate binding site (hereafter referred to as ‘site
2’), approximately 38 Å from the active site P-loop and
about 35 Å from the putative focal complex targeting loop
comprised of residues 223–226 (Fig. 2A). The structure




. (2003) also contains a peptide
bound to site 2. These authors suggested that site 2 could









., 2003). The electron density at site 2 clearly defines
at least five of the six peptide side-chain positions
(Fig. 2B). In contrast, peptide electron density at the active
site of the difluorophosphonate structure clearly shows
only three to four of the side-chains, and only the phos-




structure (data not shown). The better density at site 2
may be indicative of a tighter affinity than the active site
or it may result from an arginine from another molecule in
the unit cell (data not shown) that makes hydrogen bonds
to the phosphotyrosine.
As shown in Fig. 2A, the DADEdfpYL phosphopeptide



























, 1994). The conformation of the pep-





of the specific interactions are to the phosphotyrosine
residue, which lies parallel to the protein surface, rather
than buried in a deep pocket as it is in the active site. Two
charged residues ligate the phosphonate (Fig. 2C):


























bridge with the phosphate similar to what is observed with
the catalytic Arg in the active site. Lys342 forms a salt-
bridge to the phosphonate oxygens as well as one fluorine




1 position) of the peptide. Two Ser
residues also make hydrogen bonds to the phosphonate
oxygens. Lys386 forms a hydrogen bond with the Glu4
carbonyl and non-polar contacts with the phosphonate
ring. Other peptide main-chain atoms also make hydrogen
bonds with the protein (Fig. 2C). The specific interactions
with the phosphonate suggest that pTyr is probably the
primary determinant of specificity for peptides binding to
this site. As there are few other specific interactions with
the other side-chains (except for Glu4), this binding site
may accommodate a variety of pTyr-containing
sequences such as those observed in the multiple phos-
phorylation motifs present in the Cas natural substrate.
To determine whether site 2 is important for interaction




, we introduced a Lys342 to Ala




 protein to inactivate





) showed reduced localization to











Site 2 in YopH is important for substrate 





 for 2 h. The strains 
used carried an empty vector (vector), and 


























A–D. Subcellular localization of mutant YopH 
proteins was examined by immunofluorescence 
microscopy using a monoclonal antibody spe-
cific to the M45 epitope appended to each of 
the mutant YopH proteins. Arrows point to focal 
adhesions, and arrowheads point to infecting 
bacteria that also stain with the antibody.
E and F. Binding of Cas (p130) to mutant YopH 
proteins was examined by co-immunoprecipita-
tion and immunoblotting. Mutant YopH proteins 
were immunoprecipitated from lysates of the 
infected cells using anti-M45. Immunoblots 
were developed with anti-M45 to control for 
YopH recovery (F) or anti-pTyr antibodies to 
detect Cas (p130) (E).
G. Lysates of uninfected or cells infected for 2 h 
were analysed by immunoblotting with anti-pTyr 
to detect dephosphorylation of Cas (p130) and 
paxillin (p68). Positions of molecular weight 
standards are shown on the left.
 


















cytosol of the infected cells (compare Fig. 1B and C). In





cells was reduced as compared with the controls (Fig. 1E
and F, lane 4). These results suggest that site 2 is involved




. The K342A mutation is
not expected to diminish the intrinsic catalytic activity of
YopH, as it is distant from the A site. To confirm that the
K342A mutation does not inhibit intrinsic catalytic activity,








, which is only mutated in site
2. Dephosphorylation of total cellular proteins after a 2 h
infection was examined by anti-pTyr immunoblotting. As
shown in Fig. 1G, bands of 130 kDa (p130) and 68 kDa





. These bands have previously been shown to
correspond to Cas and paxillin respectively (Black and









 did not have diminished catalytic activity was





 did not localize to focal adhesions
(Fig. 1A), and did not co-precipitate with Cas (Fig. 1E and
F, lane 2).
To determine whether sites 1 and 2 can function inde-
pendently to bind substrate, mutations designed to inac-
tivate site 1, or site 1 and site 2, were introduced into the









 strains producing these pro-
teins, substrate-binding activity was measured using
immunofluorecence microscopy and immunoprecipitation.





) reduced, but did not eliminate, focal adhesion
localization (Fig. 3B) or Cas binding (Fig. 3D–F, lane 5).





focal adhesion localization activity (Fig. 3A) and dimin-
ished, but did not eliminate, interaction of YopH with Cas





) further reduced the ability of YopH to bind
Cas (Fig. 3D–F, lane 4). Densitometry was used to mea-
sure the signal intensities of the Cas bands detected in
Fig. 3E, and these signals were normalized to the
amounts of Cas present in lysates before immunoprecip-
itation (Fig. 3G). The calculations show that inactivation of
site 2 decreased Cas binding by approximately twofold in











ª24-fold in the context of a mutated site 1
(YopHVGRA versus YopHVGKARA). These results show that
sites 1 and 2 can function independently to bind Cas in
host cells (Fig. 3H). Of the two, site 1 appears to bind
more avidly to Cas, which may explain why site 1 is suf-
ficient for focal adhesion localization.
To confirm that site 2 binds Cas directly, we carried out
an in vitro binding reaction with purified proteins. Purified
Cas protein was phosphorylated using the Src kinase. As
shown in Fig. 4A, phosphorylation of Cas (p-Cas) was
evident by a decreased mobility during SDS-PAGE, and
increased reactivity with anti-pTyr antibody. The catalytic
domains (CDs; residues 172–468) of YopH proteins with
mutations in A site or site 2, or both, were purified as GST
Table 1. Diffraction and refinement statistics for YopH–peptide complexes.
YopHC403S (163–468) +
Ac-DADE(pY)L-NH2
YopH (163–468) + 
Ac-DADE(dfpY)L-NH2








Resolution (Å) 20–3.0 50–2.5
Number of reflections 10084 18319
Rmerge 0.118 0.075
Completeness (%) 86 85.5
Number of protein molecules 2 2
Protein residues 182–468 (A) 187–468 (A)




5 (A, site 2)
4 (A, active)
6 (A, site 2)
1 (B, active) 4 (B, active)
5 (B, site 2) 6 (B, site 2)
Total number of atoms 4588 4831
Number of waters 89 297
Rwork/Rfree 0.181/0.249 0.178/0.229
rmsd bonds (Å) 0.008 0. 007
rmsd angles (∞) 1.18 1.18
pY, phosphotyrosine; dfpY, difluorophosphonomethyl-phenylalanine; rmsd, root mean square deviation.
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fusion constructs (GST–YopHCD). GST fusion proteins
were bound to beads, incubated with p-Cas, and after
washing, the amount of p-Cas bound to the GST fusion
proteins was measured by anti-Cas immunoblotting. The
highest level of binding to full-length Cas and several Cas
truncation products was observed with the positive control
YopHCDC403S construct (Fig. 4B, lane 2). Mutation of the
catalytic Cys residue at position 403 to Ser results in
trapping of substrates at the active site (Guan and Dixon,
1990; Bliska et al., 1991; Montagna et al., 2001).
Reduced Cas-binding activity was observed when 10-fold
less YopHCDC403S was bound to the beads (lane 1). In
addition, when YopHCDR409A and YopHCDKARA were used
in binding reactions, less Cas bound to the latter con-
struct, indicating that site 2 binds directly to tyrosine-
phosphorylated Cas (compare lanes 3 and 4).
To evaluate the importance of sites 1 and 2 for the
biological activity of YopH, HeLa cells were infected with
Y. pseudotuberculosis strains producing catalytically
active YopH proteins with mutations in site 1, site 2 or both.
Rounding and detachment of the HeLa cells in response
to disruption of focal adhesions by YopH activity was mea-
sured by phase contrast microscopy, and by a quantitative
viable cell assay (MTT assay). As shown in Fig. 5, wild-
type YopH caused ª80% of the HeLa cells to detach
(Fig. 5B and G), while the catalytically inactive YopHR409A
protein did not cause any detachment (Fig. 5C and G).
Approximately 60% of the cells detached when site 1
(YopHV31G) or site 2 (YopHK342A) were inactivated, while
fewer cells detached (ª40%) when both sites were inacti-
vated (YopHVGKA) (Fig. 5D–G). Therefore, sites 1 and 2 co-
operate to promote cell detachment by YopH in an in vitro
infection assay.
A mouse infection assay (Bliska et al., 1991) was used
to evaluate the importance of site 1 and site 2 for the
virulence function of YopH. Y. pseudotuberculosis is highly
lethal for mice via the intravenous route of infection; this
infection model approximates the systemic phase of
plague (Une and Brubaker, 1984). Mice were infected with
an equal mixture of a test strain and a chloramphenicol-
resistant yopH::cam null mutant as a reference strain. The
ability of mutant test strains to out-compete the reference
strain for colonization of the spleen was determined by a
competitive index (CI) assay. Test strains contained
mutant yopH alleles introduced into the native location on
the virulence plasmid. A test strain used as a wild-type
control was constructed by introducing a silent mutation
resulting in an Nde restriction site at the yopH initiation
codon (yopHNde). As shown in Fig. 6, the wild-type test
strain (yopHNde) out-competed the reference strain by a
factor of ª100 (geometric mean of control CI = 0.015). In
contrast, the test strain expressing catalytically inactive
YopH (yopHR409A) did not out-compete the reference strain
(geometric mean CI = 2.54). Test strains mutated in the
Fig. 2. Crystal structures of YopH catalytic domain complexed with 
phosphotyrosine (pY)- or phosphonodifluoromethyl-phenylalanine 
(dfpY)-containing peptides.
A. Cartoon representation of the dfpY-containing peptide complex 
showing location of peptides bound to the active site P-loop (A site) 
and site 2. The location of the putative focal complex targeting loop, 
residues 223–226, is also shown.
B. Simulated annealing Fobs–Fcalc omit electron density of the bound 
pY-containing peptide at site 2. Density is well resolved for residues 
2–6.
C. Close-up of the dfpY peptide (yellow) at site 2 showing potential 
hydrogen bonds with the protein structure (blue).
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focal contact targeting loop (yopHD223-226), in site 2
(yopHK342A) or in site 1 (yopHV31G), had geometric mean CI
values of 0.011, 0.014 and 0.023, respectively, and the CI
data for these competitions were not significantly different
(unpaired Student’s t-test) from the control competition.
The competition data for the test strain mutated in sites 1
and 2 (yopHVGKA) (geometric mean CI = 0.033) was signif-
icantly different (P = 0.044) from the control competition
(Fig. 6). Therefore, sites 1 and site 2 in YopH co-operate
to promote substrate targeting in vivo, and this activity is
important for Yersinia virulence.
Discussion
It is well established that targeting domains play a key role
in substrate recognition by PTPs (Mauro and Dixon, 1994;
Tonks and Neel, 2001). As shown here, substrate recog-
nition by YopH involves two substrate-targeting sites that
function in a cooperative manner. Other PTPs, such as
SHP-2, contain duplicate substrate-targeting domains in
the form of tandem SH2 domains (Tonks and Neel, 2001).
In the case of SHP-2, the phosphotyrosine residues rec-
ognized by the SH2 domains serve as docking sites for
the enzyme, but are not dephosphorylated by the catalytic
domain. In contrast, the phosphotyrosine residues that
are recognized by sites 1 and 2 in YopH may serve as
docking sites initially, but are ultimately dephosphorylated
by the catalytic domain. The substrate region of Cas con-
tains multiple phosphorylation sites that are on average
21 residues apart (Bouton et al., 2001). It is likely that
sites 1 and 2 allow YopH to act in a highly processive
manner to dephosphorylate the substrate region of Cas.
However, the finding that site 2 is on the opposite side of









Fig. 3. Sites 1 and 2 can function indepen-
dently to bind Cas in host cells. HeLa cells were 
infected and processed as in the legend to 
Fig. 1. The Y. pseudotuberculosis strains 
expressed no YopH (vector), YopHV31GR409AM45 
(VGRA), YopHV31GK342A409AM45 (VGKARA), 
YopHK342AR409AM45 (KARA) or YopHR409AM45 
(R409A).
A–C. Subcellular location of mutant YopH pro-
teins as determined by immunofluorescence 
microscopy.
D–F. Co-immunoprecipitation of Cas with 
mutant YopH proteins was examined by immu-
noblotting with anti-pTyr, anti-Cas or anti-M45 
antibodies.
G. Samples of infected cell lysates that were 
used for immunoprecipitations were analysed 
by immunoblotting with anti-Cas antibodies.
Densitometry was used to measure the signal 
intensities of the Cas bands in lanes 2–5 of (E) 
and (G). Signal intensities of immunoprecipi-
tated Cas bands (E) were normalized to the 
signal intensities of the Cas bands in the 
lysates (G). The signal intensity of the Cas band 
in lane 2 of (E) is assigned an arbitrary value 
of 1. The corresponding signal intensities of the 
other bands are indicated below (E) (signal).
H. Model depicting YopH interacting with a mul-
tiply phosphorylated (P) substrate through sites 
1 and 2. The active site (A) is represented in a 
non-substrate-trapping form (R409A mutant). 
Mutant proteins are depicted in order of 
increasing substrate binding strength (from bot-
tom to top, following direction of arrow).
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site 1 and the A site could simultaneously engage phos-
photyrosine residues on the same Cas molecule. The
model shown at the top of Fig. 3H illustrates a conforma-
tion in which sites 1 and 2 are engaged on a single Cas
molecule, leaving the A site exposed to dephosphorylate
an adjacent Cas molecule. It will be necessary to deter-
mine the structure of full-length YopH in complex with a
model substrate to further elucidate the mechanism of
substrate recognition.
Cas contains 15 phosphorylation sites with a consen-
sus motif (D/E)(V/I)pY(D/Q)VPP, which contains the pre-
ferred consensus motif (pY)XXP for the SH2 domain of
the Crk protein (Bouton et al., 2001). In this light, it is
interesting to compare the mode of phosphopeptide bind-
ing to site 2 with phosphopeptide binding to Crk SH2
domain (PDB id 1JUF). In both structures, the phospho-
tyrosine moiety binds with its ring approximately parallel
to the protein surface, located on loops between b-strands
and near the N-terminus of an a-helix. In both cases an
Arg and one or more serines are involved in ligating the
phosphate moiety.
The EGFR-derived peptide used in this study does not
contain the residues following the phosphotyrosine resi-
dues that are present in the p130Cas phosphorylation
sites. Nevertheless, we speculate that a Cas-derived pep-
tide would bind similarly. As the P+1 (Leu) side-chain in
the present structure points towards Arg337, we propose
that the Cas P+1 Asp would form an ionic interaction with
that residue. The subsequent three hydrophobic residues
V–P–P might bind in a relatively hydrophobic cleft
between the a4-helix and three b-strands of the nearby b-
sheet. Additional YopH–phosphopeptide complex struc-
tures will need to be solved to confirm this hypothesis.
Experimental procedures
Protein crystallography
The catalytic domain of YopH and YopHC403S (residues 163–
468) from Y. enterocolitica were purified as described (Zhang
et al., 1992). Both of these constructs contain the C235R
mutation shown not to affect catalytic activity. The phosp-
hotyrosine peptide acetyl-DADE(pY)L-NH2 was synthesized
at the University of Michigan Protein Core facility and the
difluorophosphonomethyl-phenylalanine-containing peptide
of the same sequence was kindly provided by Dr Robert
Zamboni and Dr Michael Gresser, Merck Frosst, Montreal.
YopHC403S (163–468) at a concentration of 10–12 mg ml-1 was
pre-incubated with 1 mM of the pY-containing peptide and
then mixed with an equal volume of precipitant containing
18–24% polyethylene glycol (PEG) 8000, 50–100 mM NaCl,
0.1% b-mercaptoethanol, 100 mM TrisCl, pH 8.5. Seeding of
the rod-shaped crystals gave crystals as large as
0.8 ¥ 0.4 ¥ 0.4 mm3. Diffraction intensities were measured on
an SDMS multiwire detector at room temperature and pro-
cessed with MADNES (Messerschmidt and Pflugrath, 1987).
Molecular replacement with the 1YTS structure was per-
formed in X-PLOR, and the two protein complexes in the unit
cell were refined with data to 3.0 Å resolution with crystallog-
raphy and NMR system (CNS) (Brunger et al., 1998) with
non-crystallographic symmetry restraints. To crystallize the
complex with the difluorophosphonomethyl-phenylalanine-
containing peptide, YopH (163–468) at 10 mg ml-1 in 1 mM
imidazole, pH 7.5 was incubated with 0.5 mM peptide (final
concentration) for 1 h at room temperature. Protein was
Fig. 4. The catalytic domain of YopH binds directly to tyrosine-
phosphorylated Cas and site 2 is important for this activity.
A. Purified non-phosphorylated Cas protein (–Src) and Cas phospho-
rylated by v-Src kinase (+Src) were analysed by immunoblotting with 
anti-Cas or (lanes 1 and 2) anti-pTyr (lanes 3 and 4) antibodies. 
Positions of non-phosphorylated Cas and phosphorylated Cas 
(p-Cas) are indicated.
B. GST fusion proteins containing catalytic domains of mutant YopH 
proteins were immobilized on beads (0.1 or 1 mg input), incubated 
with p-Cas, and after washing, the amount of p-Cas bound to the GST 
fusion proteins was measured by anti-Cas immunoblotting. The GST 
fusion proteins contained the catalytic domains of YopHC403SM45 (CS), 
YopHR409AM45 (RA) or YopHK342AR409AM45 (KARA).
C. Recovery of GST fusion proteins on the beads was 
measured by anti-YopH immunoblotting. The positions of bands 
corresponding to the GST–YopH catalytic domain (CD) proteins are 
indicated.
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mixed with precipitant containing 22% PEG 4000, 8 mM
MnCl2, 0.1% b-mercaptoethanol, 100 mM Hepes, pH 7.5,
and equilibrated by microvapour diffusion against the same
precipitant. See Table 1 for data and refinement statistics.
Co-ordinates are available from the Protein Data Bank
(http://www.rcsb.org/pdb) as 1XXP and 1XXV.
Bacterial strains
The Y. pseudotuberculosis strains used for HeLa cell infection
assays were derived from YP17 (yopH::cam yopE::kan)
(Montagna et al., 2001). Plasmids derived from pMMB76HE
which encode wild-type or mutant forms of YopH with
appended M45 epitope tags (pPYopHM45, pPYopHR409AM45,
pPYopHV31GM45 and pPYopHV31GR409AM45) have been previ-
ously described (Montagna et al., 2001). Plasmids encoding
additional mutant forms of YopHM45 (pPYopHK342AM45,
pPYopHK342AR409AM45, pPYopHV31GK342AR409AM45 and
pPYopHDR409AM45) were constructed in the same vector using
appropriate oligonucleotides and polymerase chain reac-
tions. Plasmids were introduced into YP17 by conjugation
(Montagna et al., 2001).
Yersinia pseudotuberculosis strains used in mouse infec-
tion studies were IP9 (yopH::cam), and additional yopH
mutants derived from IP9 (Bliska et al., 1991). Mutant yopH
alleles (yopHNde, yopHV31G, yopHD223-226, yopHK342A, yopHR409A
and yopHVGKA) were introduced onto the virulence plasmid
carried by IP9 using the plasmid pSB890 and a standard
allelic recombination strategy (Palmer et al., 1998). Following
allelic recombination isolated colonies of Y. pseudotubercu-
losis were tested for loss of tetracycline resistance (to confirm
excision of pSB890) and loss of chloramphenicol resistance
(to confirm replacement of the yopH::cam allele). The pres-
ence of the virulence plasmid was verified by patching colo-













Fig. 5. Sites 1 and 2 co-operate to promote 
YopH cell detachment activity. HeLa cells were 
infected with yopH mutant Y. pseudotuberculo-
sis strains for 1 h, bacteria were then killed by 
addition of gentamicin, and the cultures were 
incubated for an additional 18 h. Unbound cells 
were removed by washing.
A–F. Representative phase contrast images 
were captured by digital photomicroscopy.
G. Viable cells were quantified using an MTT 
assay. Results were normalized to uninfected 
cells. Results shown are the means and stan-
dard deviations of values obtained from three 
different wells for each condition performed in 
a single experiment and are representative of 
three independent experiments. The yopHVGKA 
mutant promoted significantly less cell detach-
ment than either the yopHVG or the yopHKA 
mutant (P < 0.001).
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Toma, 1989). Polymerase chain reaction was used to amplify
the yopH sequences from prospective recombinants and the
presence of the appropriate mutation was confirmed by
sequencing. For infection assays, bacterial cultures were
grown overnight at 28∞C with shaking in Luria broth (LB),
diluted in fresh media to an OD600 of 0.1 and grown with
shaking at 37∞C as described below.
In vitro binding reaction
Cas and v-Src were tagged at the N-terminus with polyhisti-
dine and purified as described previously (Goldberg et al.,
2003). In vitro kinase reactions with Cas and v-Src were
performed as described previously (Goldberg et al., 2003).
Plasmids that encode mutant forms of YopH catalytic
domains fused to GST were constructed using pGEX-KG as
described (Black et al., 2000). DNA fragments encoding res-
idues 172–468 of the different mutant yopH alleles
(yopHC403S, yopHR409A and yopHKARA) with appended M45 tags
were inserted between the SmaI and EcoRI sites of pGEX-
KG. GST fusion proteins were expressed in E. coli TUNER
cells (Novagen) and purified on GSTrap FF columns (Amer-
sham Biosciences) using conditions suggested by the man-
ufacturer. To start the binding reactions, 0.1 or 1 mg of purified
GST fusion protein were diluted into 500 ml of binding buffer
[phosphate-buffered saline (PBS)/1% BSA] and mixed with
20 ml of glutathione sepharose 4B (Amersham Biosciences).
After 60 min incubation at room temperature, the beads were
washed three times with binding buffer. Tyrosine-phosphory-
lated Cas (2.5 ng per reaction) was diluted into 500 ml of
binding buffer containing 1 mM NaVO4 and 10 mM NaF, and
incubated with the beads pre-loaded with GST fusion protein.
After incubation for 60 min at room temperature, the beads
were washed twice with binding buffer containing 1 mM
NaVO4 and 10 mM NaF and twice with PBS containing 1 mM
NaVO4 and 10 mM NaF. The amount of Cas and GST fusion
protein bound to the beads was measured by immunoblotting
as described (Montagna et al., 2001).
HeLa cell infection
Yersinia pseudotuberculosis cultures were grow in LB con-
taining 2.5 mM CaCl2 and used to infect HeLa cells for im-
munoprecipitation, immunoblotting or immunofluorescence
microscopy assays as described (Montagna et al., 2001).
Immunoprecipitation, immunoblotting or immunofluores-
cence microscopy assays were performed as described
(Montagna et al., 2001).
Yersinia pseudotuberculosis cultures used for MTT assays
were grown in LB containing 20 mM MgCl2 and 20 mM
sodium oxalate for 1 h at 26∞C and 2 h at 37∞C. The cultures
were washed with PBS and used to infect HeLa cells (1 ¥ 105
per well in a 24-well tissue culture plate) at multiplicity of
infection of 100. After 1 h of infection, the HeLa cells were
washed once with PBS, and incubated in fresh medium
containing 100 mg ml-1 gentamicin. At 19 h post infection
detached cells were removed by washing with PBS and fresh
media containing 500 mg ml-1 MTT (Sigma M-5655) was
added to each well. After 4 h of incubation at 37∞C/5% CO2
the media was removed by aspiration and 100 ml of DMSO
was added to each well. After 3 min incubation at room tem-
perature, 900 ml of 0.04 N HCl-acidified isopropanol was
added to each well and the plate was shaken thoroughly for
5 min. The absorbance of each sample at 570 nm was mea-
sured with a spectrophotometer (model ELx800, BIO-TEK
Instruments). Values obtained from three different wells for
each condition were averaged. Statistical significance was
evaluated using one-way analysis of variance (ANOVA) and
Tukey-Kramer Multiple Comparisons Test (Instat Version
2.01). A P-value of <0.05 was considered significant in indi-
vidual comparisons.
Mouse infection
Yersinia pseudotuberculosis cultures for mouse infections
were grown in LB for 3 h at 37∞C. The cultures were washed
in PBS and diluted to 104 colony-forming units (cfu) per mil-
lilitre. Each of the test strains was mixed with an equal volume
of the reference strain (IP9, yopH::cam) and 100 ml of the
mixture was injected into the tail vein of a 6- to 8-week-old
female BALB/c mouse (Taconic). Input cfu (ª500 cfu of each
strain, total of ª1000 cfu) in each mixture was determined by
plating on LB agar or LB agar containing chloramphenicol
(30 mg ml-1). Mice were euthanized 4 days post infection.
Spleens were removed and homogenized in 4.5 ml of PBS.
The total number of output cfu per spleen was determined
by plating serial dilutions of the homogenates on LB agar.
The number of output cfu corresponding to IP9 per spleen
was determined by replica plating onto LB agar containing
Fig. 6. Sites 1 and 2 co-operate to promote the virulence function of 
YopH in mice. Mice were infected intravenously with ª500 cfu of a 
Y. pseudotuberculosis test strain (yopHNde, yopHD223-226, yopHK342A, 
yopHV31G, yopHVGKA or yopHR409A) mixed with ª500 cfu of the reference 
yopH::cam mutant. Four days post infection the mice were eutha-
nized, the spleens were removed and homogenized, and dilutions of 
the homogenates were plated to enumerate output cfu of the refer-
ence strain (camR) and the test strain (camS). Competitive index (CI) 
values (filled circles) were transformed logarithmically to determine 
geometric means (horizontal bars) and P-values. The difference 
between the CI data for the yopHVGKA competition and the yopHNde 
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chloramphenicol (30 mg ml-1). CI values were calculated
using the following formula:
(IP9 output cfu/test strain output cfu)/(IP9 input cfu/test strain 
input cfu)
Competitive index values were transformed logarithmically,
and a two-tailed unpaired Student’s t-test (InStat, version
2.01) was used to determine P-values, comparing the CI
values from the IP9/yopHNde competition with CI values from
other competitions.
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